A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2006
06/08/2006	WO2006017347B1 Opthalmic compositions and methods for treating ophthalmic conditions
06/08/2006	WO2006005578A3 Solid pharmaceutical composition comprising mirtazapine
06/08/2006	WO2006002887A8 Aqueous drink solution of indibulin (d-24851) and an organic acid
06/08/2006	WO2005122734A3 Nanosphere/microsphere delivery system for the treatment of spinal cord injury
06/08/2006	WO2005120467A3 Dosage form containing the active ingredient cholylsarcosine
06/08/2006	WO2005099671A3 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
06/08/2006	WO2005087193A3 Chemoembolisation involving an anthracycline compound
06/08/2006	WO2005082329B1 Process for the preparation of solid dosage forms of valsartan and hydrochlorthiazide
06/08/2006	WO2005079748A3 Pharmaceutical preparation for sustained release of a pharmaceutically active ingredient
06/08/2006	WO2005079204A3 Artificial synapse chip
06/08/2006	WO2005076987A3 Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
06/08/2006	WO2005072228A3 Preparation of capsules
06/08/2006	WO2005027996A3 Application of a therapeutic substance to a tissue location using an expandable medical device
06/08/2006	WO2005020906A3 Intranasal opioid compositions
06/08/2006	WO2004050020A3 Improved opioid pharmaceutical compositions
06/08/2006	WO2003057150A3 A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
06/08/2006	US20060122863 Patient management network
06/08/2006	US20060122659 Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
06/08/2006	US20060122578 Implantable medication delivery device
06/08/2006	US20060122577 Modular drug delivery system
06/08/2006	US20060122576 Fluid delivery system for use with a surgical pumping unit
06/08/2006	US20060122432 Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol
06/08/2006	US20060122374 Albumin-fused anti-angiogenesis peptides
06/08/2006	US20060122290 Multifunctional polymeric tissue coatings
06/08/2006	US20060122275 Agentfor reducing side effects of diclofenac
06/08/2006	US20060122271 Stable gabapentin having pH within a controlled range
06/08/2006	US20060122265 Process for modifying drug crystal formation
06/08/2006	US20060122200 Use and application of a pharmaceutical composition containing a mixture of natural- origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
06/08/2006	US20060122194 Tablet comprising efletirizine and pseudoephedrine
06/08/2006	US20060122163 adding temozolomide with dissolution enhancing agent is selected from L-histidine, L-threonine, L-asparagine, L-serine, and L-glutamine; freeze drying
06/08/2006	US20060122142 DNA vaccines for farm animals, in particular bovines and porcines
06/08/2006	US20060122097 Uptake of macromolecules
06/08/2006	US20060122095 Mucus formulation for mucosal surfaces and uses thereof
06/08/2006	US20060121127 Stabilized lanthanum carbonate compositions
06/08/2006	US20060121123 Forming image of sample and coated microparticle mixture by exposing to electromagnetic radiation of infrared or ultraviolet frequency; optical coherence tomography, holography, endoscopy; light, confocal, polarization, interference, and/ormulti-photon microscopy
06/08/2006	US20060121122 Process for producing microcapsule
06/08/2006	US20060121121 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion
06/08/2006	US20060121120 Sustained release ionic conjugate
06/08/2006	US20060121119 Process for producing nanoparticles of paclitaxel and albumin
06/08/2006	US20060121118 Antimycotic gel having high active compound release
06/08/2006	US20060121117 Anti-angiogenic compositions and methods of use
06/08/2006	US20060121116 Sol-gel chemotaxis induced concentration gradient for separation of cells/organisms within suspensions
06/08/2006	US20060121115 Composition having gelling properties for the prolonged delivery of bioactive substances
06/08/2006	US20060121114 Method of manufacturing sustained release microbeads containing venlafaxine HCL
06/08/2006	US20060121113 Pharmaceutical composition containing 6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol with delayed active ingredient release
06/08/2006	US20060121112 Topiramate pharmaceutical composition
06/08/2006	US20060121111 Formulations of substituted benzoxazoles
06/08/2006	US20060121110 Formulations of substituted benzoxazoles
06/08/2006	US20060121109 Formulations of substituted benzoxazoles
06/08/2006	US20060121108 System and method for producing a directly compressible, high-potency formulation of metformin hydrochloride
06/08/2006	US20060121107 Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same
06/08/2006	US20060121106 Therapeutic system comprising amoxicillin and clavulanic acid
06/08/2006	US20060121105 Method of lipid structure preparation
06/08/2006	US20060121104 Transdermal delivery system for dried particulate or lyophilized medications
06/08/2006	US20060121103 Transdermal delivery system
06/08/2006	US20060121102 Transdermal systems for the delivery of estrogens and progestins
06/08/2006	US20060121099 Process for making nonwoven articles
06/08/2006	US20060121098 Dermal defense system and method of use
06/08/2006	US20060121097 Treatment articles capable of conforming to an underlying shape
06/08/2006	US20060121096 Veterinary delivery systems and methods of delivering effective agents to animals
06/08/2006	US20060121093 Tableted products including active agent
06/08/2006	US20060121092 Methods of producing coated products including active agent and products regarding same
06/08/2006	US20060121091 Cellular uptake of bioactive agents
06/08/2006	US20060121088 delivering to an external portion of the body passageway a therapeutic agent such as an antiangiogenic factor from a thread; treating stenosis or restenosis for example
06/08/2006	US20060121085 Formulations for cell-schedule dependent anticancer agents
06/08/2006	US20060121079 Delivering a dose of gold, silver or an alloy of particles having a cross-sectional diameter of >20 mu m and the same weight but a greater surface area than that of solid spheres; direct contact with tissue to release ions for uptake by macrophages without phagocytosis of particles; immunocompetence
06/08/2006	US20060121075 Manufacture of strong, lightweight carrier granules
06/08/2006	US20060121072 Topical parasiticide formulations and methods of treatment
06/08/2006	US20060121068 Low viscosity; surface treatment; spray drying slurry; heat treatment; thermoconductivity
06/08/2006	US20060121067 Menthol-containing preparation
06/08/2006	US20060121066 Sucralose formulations to mask unpleasant tastes
06/08/2006	US20060121059 Vaccine composition
06/08/2006	US20060121021 by which blood cells can be stimulated; amount of required mAbs is lower than when using the same mAbs in a solution, which makes the stimulation independent from the presence or the quality of non-T cells carrying Fc-receptors, and which can be prepared in an easier way under GMP conditions
06/08/2006	US20060121015 Probiotic bifidobacterium strains
06/08/2006	US20060120992 Rapid dehydration of proteins
06/08/2006	US20060120977 Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
06/08/2006	US20060120974 Nicotine delivery systems
06/08/2006	US20060120973 powders containing human growth hormone; for treatment or prevention of growth retardation, growth hormone deficiency, or for control of HIV-related wasting and cachexia
06/08/2006	US20060120972 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
06/08/2006	US20060120971 Agents and methods for administration to the central nervous system
06/08/2006	US20060120970 exposing a lactose mixture which does not exclusively contain alpha-lactose-monohydrate to a relative humidity of at least 85% to provide a lactose which contains exclusively alpha-lactose-monohydrate having a desorption heat of less than 40 J/g.; surface-energy passivation of lactose
06/08/2006	US20060120969 Inhalers used in the treatment of diabetes by delivering insulin by way of systemic dose delivery
06/08/2006	US20060120966 Salmeterol superfine formulation
06/08/2006	US20060120962 Cardiac safe, rapid medication delivery
06/08/2006	US20060118003 Light-blocking agent and film-forming composition
06/08/2006	US20060118000 Water dispersible compositions containing natural hydrophilic water-insoluble pigments, methods of preparing same and their use
06/08/2006	DE20122582U1 Zubereitung für Restenoseprophylaxe Preparation for prophylaxis of restenosis
06/08/2006	DE102004057587A1 Wässrige Dispersionen eines Gemisches schwer wasserlöslicher oder wasserunlöslicher Wirkstoffe und eines Einzellerproteinmaterials und daraus hergestellte Trockenpulver Aqueous dispersions of poorly water-soluble or water-insoluble mixture of active ingredients and a single-cell protein material and derived dry powder
06/08/2006	CA2628777A1 Liposomal formulation for oral administration of glutathione (reduced)
06/08/2006	CA2589824A1 Nanoparticulate benzothiophene formulations
06/08/2006	CA2589736A1 Coated drug delivery formulations
06/08/2006	CA2589537A1 Pharmaceutical compositions of amorphous atorvastatin and process for preparing same
06/08/2006	CA2589489A1 Method of providing fast relief to a user of a nicotine chewing gum
06/08/2006	CA2589484A1 Methods of using temozolomide formulation intrathecally in the treatment of cancers
06/08/2006	CA2589453A1 Pharmaceutical formulations
06/08/2006	CA2589397A1 Viscoelastic solutions containing sodium hyaluronate and hydroxypropyl methyl cellulose, preparation and uses
06/08/2006	CA2589118A1 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
06/08/2006	CA2589103A1 Formulations of substituted benzoxazoles
06/08/2006	CA2589033A1 Formulations of substituted benzoxazoles
06/08/2006	CA2588823A1 Silver treated phosphorylated cotton product

1 ... 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 ... 2991